PSMA PET/CT doubles prostate cancer detection in men with inconclusive MRI scans
A PSMA PET/CT scan can double the detection rate for prostate cancer in men whose MRI was inconclusive. Image generated by WIX AI CANCER DIGEST – Oct. 18, 2026 – A small study combining two diagnostic imaging techniques found the combination doubled the detection rate for prostate cancer without the need for invasive needle biopsy. Led by Andrea Farolfi, MD at the Azienda Ospedaliero-University of Bologna, Italy, the single-center study looked at combining PSMA PET and CT sca


Immunotherapy before surgery shows remarkable cancer-free durability for certain colorectal cancers
Patients with a specific type of bowel cancer treated with immunotherapy before surgery remained cancer free 33 months after treatment, results of a clinical trial show.


Urine test may improve bladder cancer diagnosis and guide treatment decisions
A simple urine test devised by researchers at Stanford Health Care and the Veterans Administration Palo Alto Health Care System can diagnose people with bladder cancer more accurately than current standard methods.


Prolonged sitting interrupted by light activity may play a role in reducing cancer risk
Interrupting prolonged sitting with light daily activity can reduce a person's risk of cancer. Image credit Backcare and Acupuncture Clinics, UK CANCER DIGEST – Sept. 20, 2026 – Uninterrupted sitting for prolonged periods of time can boost the risk of dying of cancer by 9 percent according to a new study published in the journal PLOS, the peer reviewed journal of the Public Library of Science. The July 1, 2026 study was led by Frederick Ho of the University of Glasgow, UK, an


A new approach to blood tests for cancer yields promising results
A new type of blood test is showing promise of being able to detect multiple liver diseases including cancer by examining fragments of DNA that circulate in the blood.


Combination therapy significantly boosts survival for certain liver cancer patients
Adding heat to destroy tumor tissue after direct doses of chemotherapy in liver cancer that cannot be treated with surgery significantly increased overall survival in selected patients, clinical trial results show.





















